single-cell genomics
Mission Bio, SequMed Ink Collaboration, Clinical Assay Codevelopment Agreement for China
The firms will work together on assays for cancer early detection, therapy selection, and disease monitoring, as well as on applications in reproductive genetics.
BioSkryb, St. Jude Expand Licensing Deal for Dx Applications of Single-Cell Tech
BioSkryb will now have an exclusive global license for clinical applications of primary template directed amplification technology.
Bio-Rad Q1 Revenues Rise 3 Percent
Bio-Rad said it is withdrawing its previously issued annual revenue guidance given the uncertainties regarding the duration and impact of the COVID-19 pandemic.
Mission Bio Lands $2M NCI SBIR Grant to Advance Minimal Residual Disease Detection
The single-cell genomics firm will collaborate with Fred Hutchinson Cancer Research Center on a targeted sequencing panel for MRD monitoring in AML.